Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.094

Metformin Suppresses MHC-Restricted Antigen Presentation by Inhibiting Co-Stimulatory Factors and MHC Molecules in APCs  

Shin, Seulmee (College of Pharmacy, Sahmyook University)
Hyun, Bobae (College of Pharmacy, Sahmyook University)
Lee, Aeri (College of Pharmacy, Sahmyook University)
Kong, Hyunseok (College of Pharmacy, Sahmyook University)
Han, Shinha (College of Pharmacy, Sahmyook University)
Lee, Chong-Kil (College of Pharmacy, Chungbuk National University)
Ha, Nam-Joo (College of Pharmacy, Sahmyook University)
Kim, Kyungjae (College of Pharmacy, Sahmyook University)
Publication Information
Biomolecules & Therapeutics / v.21, no.1, 2013 , pp. 35-41 More about this Journal
Abstract
Metformin is widely used for T2D therapy but its cellular mechanism of action is undefined. Recent studies on the mechanism of metformin in T2D have demonstrated involvement of the immune system. Current immunotherapies focus on the potential of immunomodulatory strategies for the treatment of T2D. In this study, we examined the effects of metformin on the antigen-presenting function of antigen-presenting cells (APCs). Metformin decreased both MHC class I and class II-restricted presentation of OVA and suppressed the expression of both MHC molecules and co-stimulatory factors such as CD54, CD80, and CD86 in DCs, but did not affect the phagocytic activity toward exogenous OVA. The class II-restricted OVA presentation-regulating activity of metformin was also confirmed using mice that had been injected with metformin followed by soluble OVA. These results provide an understanding of the mechanisms of the T cell response-regulating activity of metformin through the inhibition of MHC-restricted antigen presentation in relation to its actions on APCs.
Keywords
Metformin; MHC-restricted antigen presentation; Antigen-presenting cells;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A. and Klip, A. (1992) Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 131,1165-1173.   DOI   ScienceOn
2 Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V., Chandramouli, V., Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R. and Shulman, G. I. (2000) Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49, 2063-2069.   DOI   ScienceOn
3 Isoda, K., Young, J. L., Zirlik, A., MacFarlane, L. A., Tsuboi, N. and Gerdes, N., Schönbeck U. and Libby P. (2006) Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler. Thromb. Vasc. Biol. 26, 611-617.
4 Jean-Claude, M., Nicolas, W. and Geneviève, R. (2003) Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation. Br. J. Diabetes Vasc. Dis. 3, 302-310.   DOI
5 Jeng, C. Y., Sheu, W. H., Fuh, M. M., Chen, Y. D. and Reaven, G. M. (1994) Relationship between hepatic glucose production and fasting glucose concentration in patients with NIDDM. Diabetes 43,1440-1444.   DOI   ScienceOn
6 Kintscher, U., Hartge, M., Hess, K., Foryst-Ludwig, A., Clemenz, M., Wabitsch, M., Fischer-Posovszky, P., Barth, T. F., Dragun, D., Skurk, T., Hauner, H., Blüher, M., Unger, T., Wolf, A. M., Knippschild, U., Hombach, V. and Marx, N. (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler. Thromb. Vasc. Biol. 28,1304-1310.   DOI   ScienceOn
7 Kota, M., Naoki, T., Maki, Y., Jutaro, T., Hiroshi, M., Jun, M., Tadaatsu, I., Kei, S. and Toshihiro, S. (2009) Metformin restores impaired HDL-mediated cholesterol efflux due to glycation. Atherosclerosis 206, 434-438.   DOI   ScienceOn
8 Larsson, M., Fonteneau, J. F. and Bhardwaj, N. (2001) Dendritic cells resurrect antigens from dead cells. Trends Immunol. 22,141-148.   DOI   ScienceOn
9 Lee, Y. H., Lee, Y. R., Im, S. A., Park, S. I., Kim, K. H., Gerelchuluun, T., Song, S., Kim, K. and Lee, C. K. (2007) Calcineurin inhibitors block MHC-restricted antigen presentation in vivo. J. Immunol. 179, 5711-5716.   DOI
10 Lee, Y. R., Lee, Y. H., Im, S. A., Yang, I. H., Ahn, G. W., Kim, K. and Lee, J. K. (2010) Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen. Arch. Parm. Res. 33, 1859-1866.   DOI   ScienceOn
11 Lee, Y. R., Yang, I. H., Lee, Y. H., Im, S. A., Song, S., Li, H., Han, K., Kim, K., Eo, S. K. and Lee, C. K. (2005) Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 105, 3951-3955.   DOI   ScienceOn
12 Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Ronnet, G. and Diehl, A. M. (2000) Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat. Med. 6, 998-1003.   DOI   ScienceOn
13 Meijer, K., de Vries, M., Al-Lahham, S., Bruinenberg, M., Weening, D., Dijkstra, M., Kloosterhuis, N., van der Leij, R. J., van der Want, H., Kroesen, B. J., Vonk, R. and Rezaee, F. (2011) Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One. 6, e17154.   DOI   ScienceOn
14 Nath, N., Khan, M., Paintlia, M. K., Singh, I., Hoda, M. N. and Giri, S. (2009) Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J. Immunol. 182, 8005-8014.   DOI   ScienceOn
15 Sag, D., Carling, D., Stout, R. D. and Suttles, J. (2008) Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633-8641.   DOI
16 Nicolai, A., Li, M., Kim, D. H., Peterson, S. J., Vanella, L., Positano, V., Gastaldelli, A., Rezzani, R., Rodella, L. F., Drummond, G., Kusmic, C., L'Abbate, A., Kappas, A. and Abraham, N. G. (2009) Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 53, 508-515.   DOI   ScienceOn
17 Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., Yoshimura, K., Kadowaki, T. and Nagai, R. (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914-920.   DOI   ScienceOn
18 Ouchi, N., Parker, J. L., Lugus, J. J. and Walsh, K. (2011) Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85-97.   DOI   ScienceOn
19 Schafer, G. (1983) Biguanides. A review of history, pharmacodynamics and therapy. Diabetes Metab. 9, 148-163.
20 Shen, Z., Reznikoff, G., Dranoff, G. and Rock, K. L. (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723-2730.
21 Shin, S., Jung, K. S., Park, Y., Ko, Y. W., Lee, C. K., Cho, K., Ha, N. J. and Kim., K. (2011) Sulforaphane enhances MHC class II-restricted presentation of exogenous antigens. Biomol. Ther. 19, 77-83.   DOI   ScienceOn
22 Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G. and Gerich, J. E. (1995) Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 333, 550-554.   DOI   ScienceOn
23 Stunkard, A. J. (1996) Current views on obesity. Am. J. Med. 100, 230-236.   DOI   ScienceOn
24 Wu, M. S., Johnston, P., Sheu, W. H., Hollenbeck, C. B., Jeng, C. Y., Goldfine, I. D., Chen, Y. D. and Reaven, G. M. (1990) Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 13, 1-8.   DOI   ScienceOn
25 Surwit, R. S., Kuhn, C. M., Cochrane, C., McCubbin, J. A. and Feinglos, M. N. (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37,1163-1167.   DOI   ScienceOn
26 Weiser, M., Frishman, W. H., Michaelson, M. D. and Abdeen, M. A. (1997) The pharmacologic approach to the treatment of obesity. J. Clin. Pharmacol. 37, 453-473.   DOI   ScienceOn
27 Wiernsperger, N. F. and Bailey, C. J. (1999) The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs 58, 31-39.
28 Bevan, M. J. (1976) Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143,1283-1288.   DOI   ScienceOn
29 Bailey, C. J. and Turner, R. C. (1996) Metformin. N. Engl. J. Med. 334, 574-579.   DOI   ScienceOn
30 Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.   DOI   ScienceOn
31 Brossart, P. and Bevan, M. J. (1997) Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90,1594-1599.
32 DeFronzo, R. A. (1988) The triumvirate: b-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37, 667-687.   DOI
33 Han, S., Song, Y., Lee, Y. H., Lee, Y. R., Lee, C. K., Cho, K. and Kim, K. (2005) Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells. Cytokine 32, 187-193.   DOI   ScienceOn
34 Donath, M. Y. and Shoelson, S. E. (2011) Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107.   DOI   ScienceOn
35 Galuska, D., Nolte, L. A., Zierath, J. R. and Wallberg-Henriksson, H. (1994) Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM. Diabetologia 37, 826-832.   DOI
36 Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C. and Amigorena, S. (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621-667.   DOI   ScienceOn
37 Hardie, D. G. (2007) AMP-activated protein kinase as a drug target. Annu. Rev. Pharmacol. Toxicol. 47,185-210.   DOI   ScienceOn
38 Hardie, D. G., Carling, D. and Carlson, M. (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67, 821-855.   DOI   ScienceOn
39 Harding, C. V. (1995) Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biol. 5,105-109.   DOI   ScienceOn
40 Harding, C. V., Collins, D. S., Kanagawa, O. and Unanue, E. R. (1991) Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J. Immunol. 147, 2860-2863.
41 Harding, C. V. and Song, R. (1994) Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153, 4925-4933.